The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Italian Registry of Myelofibrosis with Myeloid Metaplasia
Laboratoria Di Informatica Medica
IRCCS Policlinico San Matteo
The Italian Registry of Myelofibrosis with Myeloid Dysplasia (Registro Italiano Della Mielofibrosi Con Metaplasia Mieloide or RIMM) is a non-profit registry of patients with myeloid metaplasia, a rare chronic disorder of the bone marrow that tends to affect older people. It is believed that there are approximately 300 new cases of this disorder each year in Italy. By maintaining records on enrolled patients, RIMM studies the epidemiology of the disease, its natural history, clinical research results, and treatment outcomes. Another goal is to enhance quality and continuity of care through cooperation and sharing of guidelines between research/treatment centers. RIMM was established in 1998.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.